Enrico Modena

Title: Enrico Modena: Innovating in Pharmaceutical Crystallography

Introduction

Enrico Modena, located in Medicina, Italy, is a prominent inventor in the pharmaceutical field. With a focus on developing novel crystalline forms of essential compounds, Modena has made significant contributions that enhance the therapeutic efficacy of medications.

Latest Patents

Modena holds a patent for "Crystal forms of lenvatinib," which is a groundbreaking invention. The patent describes novel crystalline forms of 4-[3-Chloro-4-(N'-cyclopropylureido)phenoxy]-7-methoxyquinoline-6-carboxamide methanesulfonate, along with innovative methods for their preparation. This invention aims to improve the stability and solubility of lenvatinib, a crucial compound used in cancer treatment.

Career Highlights

Enrico Modena works at Indena S.p.A., a company specializing in the development and production of active ingredients sourced from plants for the pharmaceutical industry. His work at Indena reflects a strong commitment to advancing drug formulations, as well as improving patient outcomes through better drug delivery systems.

Collaborations

Throughout his career, Modena has collaborated with talented professionals such as Nicola Sardone and Stefano Luca Giaffreda. These collaborations have allowed him to pool expertise and resources, fostering an environment of innovation and creativity within the sphere of pharmaceutical research.

Conclusion

Enrico Modena's contributions to pharmaceutical crystallography exemplify the importance of innovation in drug development. His patent for the crystalline forms of lenvatinib represents a significant advancement in the field, promising improved treatment options for patients. As he continues to work with his colleagues at Indena S.p.A., the future looks bright for further innovations in this vital area of medicine.